Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J Faces $360M Penalty Over Risperdal Marketing
J&J Faces $360M Penalty Over Risperdal Marketing
J&J Faces $360M Penalty Over Risperdal Marketing
Submitted by
admin
on March 23, 2011 - 10:34am
Source:
Pharmalot
News Tags:
Risperdal
JNJ
Ortho-McNeil-Janssen
Headline:
J&J Faces $360M Penalty Over Risperdal Marketing
Do Not Allow Advertisers to Use My Personal information
